Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group

Measurement of Longitudinal  -Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios

(2015) S. M. Landau et al.   JOURNAL OF NUCLEAR MEDICINE

Improved Power for Characterizing Longitudinal Amyloid-  PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region

(2015) K. Chen et al.   JOURNAL OF NUCLEAR MEDICINE

Deformation field correction for spatial normalization of PET images

(2015) Murat Bilgel et al.   NEUROIMAGE

Partial volume correction in quantitative amyloid imaging

(2015) Yi Su et al.   NEUROIMAGE

Improved longitudinal [18F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction

(2015) Matthias Brendel et al.   NEUROIMAGE

Quantitative Amyloid Imaging Using Image-Derived Arterial Input Function

(2015) Yi Su et al.   PLoS One

2014 Alzheimer's disease facts and figures

(2014)   Alzheimers & Dementia

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

(2014) L. S. Schneider et al.   JOURNAL OF INTERNAL MEDICINE

The A4 Study: Stopping AD Before Symptoms Begin?

(2014) R. A. Sperling et al.   Science Translational Medicine

Longitudinal Amyloid Imaging Using 11C-PiB: Methodologic Considerations

(2013) B. N. M. van Berckel et al.   JOURNAL OF NUCLEAR MEDICINE

Quantitative Analysis of PiB-PET with FreeSurfer ROIs

(2013) Yi Su et al.   PLoS One

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

(2013) T. L. S. Benzinger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial

(2013) S.M. Mills et al.   REVUE NEUROLOGIQUE

Noninvasive Estimation of the Arterial Input Function in Positron Emission Tomography Imaging of Cerebral Blood Flow

(2012) Yi Su et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects

(2012) A. D. Joshi et al.   JOURNAL OF NUCLEAR MEDICINE

Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?

(2012) P. Edison et al.   NEUROIMAGE

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

The importance of appropriate partial volume correction for PET quantification in Alzheimer’s disease

(2011) Benjamin A. Thomas et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Alzheimer's Disease: The Challenge of the Second Century

(2011) D. M. Holtzman et al.   Science Translational Medicine

Report of the task force on designing clinical trials in early (predementia) AD

(2010) P. S. Aisen et al.   NEUROLOGY

Alzheimer's disease therapeutic research: the path forward

(2009) Paul S Aisen   Alzheimers Research & Therapy

Automated 11C-PiB Standardized Uptake Value Ratio

(2008) Parnesh Raniga et al.   ACADEMIC RADIOLOGY

Design and Implementation of an Automated Partial Volume Correction in PET: Application to Dopamine Receptor Quantification in the Normal Human Striatum

(2008) O. G. Rousset et al.   JOURNAL OF NUCLEAR MEDICINE

Deconvolution-based partial volume correction in Raclopride-PET and Monte Carlo comparison to MR-based method

(2007) Jussi Tohka et al.   NEUROIMAGE